These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7770566)

  • 41. Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression.
    Inoue T; Tsuchiya K; Miura J; Sakakibara S; Denda K; Kasahara T; Koyama T
    Biol Psychiatry; 1996 Jul; 40(2):151-3. PubMed ID: 8793048
    [No Abstract]   [Full Text] [Related]  

  • 42. Antidepressants and psychosis in Parkinson disease: a case series.
    Voon V; Fox S; Butler TR; Lang AE
    Int J Geriatr Psychiatry; 2007 Jun; 22(6):601-4. PubMed ID: 17450623
    [No Abstract]   [Full Text] [Related]  

  • 43. Indicators of psychological distress in postacute spinal cord injured individuals.
    Osteråker AL; Levi R
    Spinal Cord; 2005 Apr; 43(4):223-9. PubMed ID: 15583705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Difficulties in the evaluation of depressive symptoms in patients with dementia].
    Schneider B; Weber B; Maurer K; Frölich L
    Psychiatr Prax; 2002 Mar; 29(2):76-82. PubMed ID: 11894187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A depressive symptom scale for the California Psychological Inventory: construct validation of the CPI-D.
    Jay M; John OP
    Psychol Assess; 2004 Sep; 16(3):299-309. PubMed ID: 15456385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychiatric outcome studies (POS): does treatment help the patients? A Popperian approach to research in clinical psychiatry.
    Bech P; Lunde M; Bech-Andersen G; Lindberg L; Martiny K
    Nord J Psychiatry; 2007; 61 Suppl 46():4-34. PubMed ID: 17365777
    [No Abstract]   [Full Text] [Related]  

  • 47. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
    Spielmans GI; McFall JP
    J Nerv Ment Dis; 2006 Nov; 194(11):845-52. PubMed ID: 17102709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluating antidepressant therapies: remission as the optimal outcome.
    Thase ME
    J Clin Psychiatry; 2003; 64 Suppl 13():18-25. PubMed ID: 14552652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patterns of early change and their relationship to outcome and follow-up among patients with major depressive disorders.
    Lutz W; Stulz N; Köck K
    J Affect Disord; 2009 Nov; 118(1-3):60-8. PubMed ID: 19217669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of response to antidepressant medication by a sign-based index of melancholia.
    Parker G; Hadzi-Pavlovic D
    Aust N Z J Psychiatry; 1993 Mar; 27(1):56-61. PubMed ID: 8481171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A preliminary study of the relationship among personality, cognitive vulnerability, symptom profile, and outcome in major depressive disorder.
    Scott J; Harrington J; House R; Ferrier IN
    J Nerv Ment Dis; 1996 Aug; 184(8):503-5. PubMed ID: 8752080
    [No Abstract]   [Full Text] [Related]  

  • 52. Sensation-Seeking Scale scores in treated geriatric depressives and controls.
    Young RC; Abrams RC; Alexopoulos GS; Shindledecker R
    Biol Psychiatry; 1989 Oct; 26(6):643-6. PubMed ID: 2790103
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluating stability and change in personality and depression.
    Santor DA; Bagby RM; Joffe RT
    J Pers Soc Psychol; 1997 Dec; 73(6):1354-62. PubMed ID: 9418283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Study on the quality of life of elderly patients with recurrent depressive disorders].
    Gnezdilov AV; Tatul'ian SE; Iavorskaia VV
    Adv Gerontol; 2006; 18():100-3. PubMed ID: 16676806
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abnormal subjective time experience in depression.
    Blewett AE
    Br J Psychiatry; 1992 Aug; 161():195-200. PubMed ID: 1355690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased β-endorphin level in blood plasma as an indicator of positive response to depression treatment.
    Kubryak OV; Umriukhin AE; Emeljanova IN; Antipova OS; Guseva AL; Pertsov SS; Sudakov SK
    Bull Exp Biol Med; 2012 Sep; 153(5):758-60. PubMed ID: 23113278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A note on some measures of profile agreement.
    McCrae RR
    J Pers Assess; 2008 Mar; 90(2):105-9. PubMed ID: 18444102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Widespread methodological problems limit validity of meta-analytic results.
    Huf W; Kalcher K; Kasper S
    Psychother Psychosom; 2011; 80(4):246; author reply 247-8. PubMed ID: 21540625
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pirasidol in clinical practice].
    Smulevich AB; Glushkov RG; Andreeva NI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(7):67-9. PubMed ID: 12938659
    [No Abstract]   [Full Text] [Related]  

  • 60. Measures of treatment outcome of depression: an effect-size comparison.
    Senra C
    Psychol Rep; 1995 Feb; 76(1):187-92. PubMed ID: 7770566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.